These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 18353766)
1. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease. Xun Z; Sowell RA; Kaufman TC; Clemmer DE Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766 [TBL] [Abstract][Full Text] [Related]
2. Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease. Xun Z; Kaufman TC; Clemmer DE J Proteome Res; 2008 Sep; 7(9):3911-21. PubMed ID: 18683964 [TBL] [Abstract][Full Text] [Related]
3. Lifetime proteomic profiling of an A30P alpha-synuclein Drosophila model of Parkinson's disease. Xun Z; Sowell RA; Kaufman TC; Clemmer DE J Proteome Res; 2007 Sep; 6(9):3729-38. PubMed ID: 17683129 [TBL] [Abstract][Full Text] [Related]
4. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila. Zhu ZJ; Wu KC; Yung WH; Qian ZM; Ke Y Biochim Biophys Acta; 2016 Apr; 1862(4):518-525. PubMed ID: 26769358 [TBL] [Abstract][Full Text] [Related]
5. Protein expression in a Drosophila model of Parkinson's disease. Xun Z; Sowell RA; Kaufman TC; Clemmer DE J Proteome Res; 2007 Jan; 6(1):348-57. PubMed ID: 17203978 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells. Pennington K; Peng J; Hung CC; Banks RE; Robinson PA J Proteome Res; 2010 May; 9(5):2390-401. PubMed ID: 20334438 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian. Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467 [TBL] [Abstract][Full Text] [Related]
15. A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease. Varga SJ; Qi C; Podolsky E; Lee D Brain Res; 2014 Oct; 1583():277-86. PubMed ID: 25130663 [TBL] [Abstract][Full Text] [Related]
16. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466 [TBL] [Abstract][Full Text] [Related]
17. Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson's Disease. He F; Qi G; Zhang Q; Cai H; Li T; Li M; Zhang Q; Chen J; Ming J; Tian B; Zhang P Cell Mol Neurobiol; 2020 Aug; 40(6):897-909. PubMed ID: 32016637 [TBL] [Abstract][Full Text] [Related]
18. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model. Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676 [TBL] [Abstract][Full Text] [Related]